Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT02906397 · COMPLETED
Trial details
- NCT number
- NCT02906397
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2021-07-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.